Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression
Open Access
- 29 November 2011
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 40 (4), 935-941
- https://doi.org/10.3892/ijo.2011.1273
Abstract
The statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) have been proven to be effective in lowering cholesterol and as anti-lipid agents against cardiovascular disease. Recent reports demonstrate an anticancer effect induced by the statins through inhibition of cell proliferation. Probably, these effects are due to suppression of the mevalonate pathway leading to the depletion of various downstream products that play an essential role in cell cycle progression, cell signaling and membrane integrity. To date, although many hypotheses have been proposed, the exact mechanism at the basis of cancer cell growth arrest induced by statins is not known. In this study, we have demonstrated that simvastatin, at a dose of 20 µM for 24‑72 h, induced in cancer cells but not in normal cells precise features of apoptosis including increased DNA fragmentation while, at the molecular level simvastatin induced overexpression of the pro-apoptotic gene Bax together with an inhibition of BCL-2, the gene that has the well-known function of protecting cells from apoptosis. The simvastatin-mediated induction of apoptosis in similar cancer cells but not in normal cells is very interesting and may be at the basis of cancer therapy using statins, usually in combination with chemotherapy or to be used as a cancer protective drug. Simvastatin may, thus, play a dual prophylactic role as a lipid-lowering drug for the prevention of heart disease and as an anticancer agent to prevent certain types of cancers.Keywords
This publication has 23 references indexed in Scilit:
- Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivinInvestigational New Drugs, 2010
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Targeting the Mevalonate Pathway Inhibits the Function of the Epidermal Growth Factor ReceptorClinical Cancer Research, 2005
- Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cellsCarcinogenesis: Integrative Cancer Research, 2005
- Blocking the Raf/MEK/ERK Pathway Sensitizes Acute Myelogenous Leukemia Cells to Lovastatin-Induced ApoptosisCancer Research, 2004
- Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse modelsCarcinogenesis: Integrative Cancer Research, 2003
- The statins as anticancer agents.2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylationAtherosclerosis, 2002
- Regulation of the mevalonate pathwayNature, 1990